Affiliations
AffiliationsItem in Clipboard
Colorectal Cancer Incidence Patterns in the United States, 1974-2013Rebecca L Siegel et al. J Natl Cancer Inst. 2017.
. 2017 Aug 1;109(8):djw322. doi: 10.1093/jnci/djw322. AffiliationsItem in Clipboard
AbstractBackground: Colorectal cancer (CRC) incidence in the United States is declining rapidly overall but, curiously, is increasing among young adults. Age-specific and birth cohort patterns can provide etiologic clues, but have not been recently examined.
Methods: CRC incidence trends in Surveillance, Epidemiology, and End Results areas from 1974 to 2013 (n = 490 305) were analyzed by five-year age group and birth cohort using incidence rate ratios (IRRs) and age-period-cohort modeling.
Results: After decreasing in the previous decade, colon cancer incidence rates increased by 1.0% to 2.4% annually since the mid-1980s in adults age 20 to 39 years and by 0.5% to 1.3% since the mid-1990s in adults age 40 to 54 years; rectal cancer incidence rates have been increasing longer and faster (eg, 3.2% annually from 1974-2013 in adults age 20-29 years). In adults age 55 years and older, incidence rates generally declined since the mid-1980s for colon cancer and since 1974 for rectal cancer. From 1989-1990 to 2012-2013, rectal cancer incidence rates in adults age 50 to 54 years went from half those in adults age 55 to 59 to equivalent (24.7 vs 24.5 per 100 000 persons: IRR = 1.01, 95% confidence interval [CI] = 0.92 to 1.10), and the proportion of rectal cancer diagnosed in adults younger than age 55 years doubled from 14.6% (95% CI = 14.0% to 15.2%) to 29.2% (95% CI = 28.5% to 29.9%). Age-specific relative risk by birth cohort declined from circa 1890 until 1950, but continuously increased through 1990. Consequently, compared with adults born circa 1950, those born circa 1990 have double the risk of colon cancer (IRR = 2.40, 95% CI = 1.11 to 5.19) and quadruple the risk of rectal cancer (IRR = 4.32, 95% CI = 2.19 to 8.51).
Conclusions: Age-specific CRC risk has escalated back to the level of those born circa 1890 for contemporary birth cohorts, underscoring the need for increased awareness among clinicians and the general public, as well as etiologic research to elucidate causes for the trend. Further, as nearly one-third of rectal cancer patients are younger than age 55 years, screening initiation before age 50 years should be considered.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
FiguresFigure 1.
Annual percent change (APC) in…
Figure 1.
Annual percent change (APC) in age-specific colon cancer incidence rates in the United…
Figure 1.Annual percent change (APC) in age-specific colon cancer incidence rates in the United States, 1974–2013. An asterisk indicates that the APC is statistically significantly different from zero (P < .05) using a two-sided test based on the permutation method. In order to highlight trends, the scale of the y-axis varies.
Figure 2.
Annual percent change (APC) in…
Figure 2.
Annual percent change (APC) in age-specific rectal cancer incidence rates in the United…
Figure 2.Annual percent change (APC) in age-specific rectal cancer incidence rates in the United States, 1974–2013. An asterisk indicates that the APC is statistically significantly different from zero (P < .05) using a two-sided test based on the permutation method. In order to highlight trends, the scale of the y-axis varies.
Figure 3.
Summary age-specific annual percent change…
Figure 3.
Summary age-specific annual percent change (i.e., local drift) and birth cohort rate ratios…
Figure 3.Summary age-specific annual percent change (i.e., local drift) and birth cohort rate ratios of colorectal cancer incidence rates in the United States. A) Local drift: summary age-specific annual percent change for colon and rectal cancer. B) Incidence rate ratios by birth cohort for colon and rectal cancer (referent cohort = 1949). Shaded bands indicate 95% confidence interval.
Comment inSiegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A. Siegel RL, et al. J Natl Cancer Inst. 2017 Aug 1;109(8):djx100. doi: 10.1093/jnci/djx100. J Natl Cancer Inst. 2017. PMID: 29117389 Free PMC article. No abstract available.
Molenaar RJ, Radivoyevitch T, Wilmink JW. Molenaar RJ, et al. J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx103. J Natl Cancer Inst. 2017. PMID: 29117390 No abstract available.
Murphy CC, Sanoff HK, Stitzenberg KB, Baron JA, Sandler RS, Yang YC, Lund JL. Murphy CC, et al. J Natl Cancer Inst. 2017 Aug 1;109(8):djx104. doi: 10.1093/jnci/djx104. J Natl Cancer Inst. 2017. PMID: 29117391 Free PMC article. No abstract available.
Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Bailey CE, et al. JAMA Surg. 2015 Jan;150(1):17-22. doi: 10.1001/jamasurg.2014.1756. JAMA Surg. 2015. PMID: 25372703 Free PMC article.
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Siegel RL, et al. CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1. CA Cancer J Clin. 2017. PMID: 28248415
Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Montminy EM, et al. Ann Intern Med. 2021 Feb;174(2):157-166. doi: 10.7326/M20-0068. Epub 2020 Dec 15. Ann Intern Med. 2021. PMID: 33315473
Stoffel EM, Murphy CC. Stoffel EM, et al. Gastroenterology. 2020 Jan;158(2):341-353. doi: 10.1053/j.gastro.2019.07.055. Epub 2019 Aug 5. Gastroenterology. 2020. PMID: 31394082 Free PMC article. Review.
Deng Y. Deng Y. Curr Treat Options Oncol. 2017 Sep 25;18(10):64. doi: 10.1007/s11864-017-0500-2. Curr Treat Options Oncol. 2017. PMID: 28948490 Review.
Mendelsohn R, Palmaira RL, Lumish M, Bacani J, Krishnan A, Weiss J, Semler R, Casson A, Arkema A, Carter J, Nelson C, Mulhall J, Garcia-Aguilar J, Stadler Z, Maya H, Cercek A. Mendelsohn R, et al. Oncologist. 2021 Aug;26(8):625-629. doi: 10.1002/onco.13849. Epub 2021 Jun 17. Oncologist. 2021. PMID: 34096669 Free PMC article.
Park L, O'Connell K, Herzog K, Chatila W, Walch H, Palmaira RLD, Cercek A, Shia J, Shike M, Markowitz AJ, Garcia-Aguilar J, Schattner MA, Kantor ED, Du M, Mendelsohn RB. Park L, et al. Int J Colorectal Dis. 2022 Dec;37(12):2511-2516. doi: 10.1007/s00384-022-04286-5. Epub 2022 Nov 28. Int J Colorectal Dis. 2022. PMID: 36441197 Free PMC article.
McHenry S, Zong X, Shi M, Fritz CDL, Pedersen KS, Peterson LR, Lee JK, Fields RC, Davidson NO, Cao Y. McHenry S, et al. Hepatol Commun. 2022 Dec;6(12):3299-3310. doi: 10.1002/hep4.2073. Epub 2022 Oct 11. Hepatol Commun. 2022. PMID: 36221229 Free PMC article.
Matos P. Matos P. Cancers (Basel). 2021 Mar 25;13(7):1500. doi: 10.3390/cancers13071500. Cancers (Basel). 2021. PMID: 33805854 Free PMC article.
Sun V, Crane TE, Arnold KB, Guthrie K, Freylersythe S, Braun-Inglis C, Jones L, Cohen SA, Al-Kasspooles M, Krouse RS, Thomson CA. Sun V, et al. Contemp Clin Trials Commun. 2021 Apr 8;22:100768. doi: 10.1016/j.conctc.2021.100768. eCollection 2021 Jun. Contemp Clin Trials Commun. 2021. PMID: 33997460 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3